MYTH 1

MYTH 1: It costs $1 billion to produce a drug because of the cost of clinical trials, and accounting for all the R&D of other medical experiments that didn’t prove successful. BUSTED! Even the big pharma boss of GSK has admitted this is “the industry’s biggest...

read more

MYTH 2

MYTH 2: We charge high prices so we have money to reinvest into new drugs. BUSTED! The majority of financial return on medicines isn’t even spent on R&D. Big pharma (obviously) aren’t keen on being transparent about this issue but as you can see from the table...

read more

MYTH 3

MYTH 3: Private investment funds medical R&D so we need to charge high prices to be accountable to these investors. BUSTED! Who pays for drug R&D? We do. A study from the Global Forum for Health Research showed that 43% of investment is fronted by public...

read more

MYTH 4

MYTH 4: Without patents there would be no medical innovation Busted! Firstly, if this was true then we wouldn’t need this campaign! - if patents really did incentivise innovation then we would have been ready for the ebola crisis and we’d already have an effective...

read more

Me Too Drugs

Fojo T et al. “Unintended consequences of expensive cancer therapeutics – the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity” JAMA Otolaryngology Head and Neck Surgery (2014). Prescrire (2014); 34 (364):132-136 ‘New drugs...

read more

The CEWG report

Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (2012) “Research and Development to meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”...

read more